ocunexus.comHealthcareFounded: 1900Funding to Date: $144.36MM
Ocunexus Therapeutics is a biotechnology company focused on inflammasome modulation for treatment of Dry Age-related Macular Degeneration and Diabetic Retinopathy.
View Enterprise Value for OcuNexus Therapeutics.